Bio-Rad Laboratories, Inc. (BIO) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 378.00 · gapped below the open, then crossed back over prior close. High/low 379.64 at 12:30 pm ET, 371.73 at 9:45 am ET.
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
3 readings, 1 filed under bull and 2 under bear. Every figure is ours; the model chose the side.
the bull case· 1
396
managers reporting a position in thirteen f filings represent broad institutional ownership
13fJun 30 '26the bear case· 2
13 of 25
largest reporting managers cut their stake in the latest quarter
13fJun 30 '2636
managers whose positions together make up four fifths of the reported value show concentration
13fJun 30 '26The model filed each reading under bull or bear and wrote its caption; a caption carrying a digit is replaced by our own phrase, so every figure on this zone is ours. Built Sep 16 '26 against the Oct 30 '26 report; rebuilt when that date rolls. Not a forecast, not advice.
tall tick = annual report · 1 on record
Bio-Rad Laboratories, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
NYSE · Laboratory Analytical Instruments
Bio-Rad Laboratories, Inc. has no measured co-movers clearing our correlation floor, so only its SEC classification is shown.
SIC 3826, Laboratory Analytical Instruments, from each company's own filings. Largest first.
BIO (Bio-Rad Laboratories, Inc.) has 0 disclosed suppliers and 2 disclosed customers, strongest disclosure first.
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: BDSX +1.09%, in healthcare.
396 managers report a position worth $5.7B between them, and 36 of them hold 80% of it.